A comparative study of some combined treatment regimens in acute toxoplasmosis in mice
Author
dc.contributor.author
Thiermann, E.
Author
dc.contributor.author
Apt Baruch, Werner
Author
dc.contributor.author
Atías, Antonio
Author
dc.contributor.author
Lorca, M.
Author
dc.contributor.author
Olguín, J.
Admission date
dc.date.accessioned
2019-01-29T15:46:06Z
Available date
dc.date.available
2019-01-29T15:46:06Z
Publication date
dc.date.issued
1978
Cita de ítem
dc.identifier.citation
American Journal of Tropical Medicine and Hygiene, Volumen 27, Issue 4, 2018, Pages 747-750
Identifier
dc.identifier.issn
00029637
Identifier
dc.identifier.other
10.4269/ajtmh.1978.27.747
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/162329
Abstract
dc.description.abstract
The effectiveness of five treatment regimens was compared in mice during acute and late infection with Toxoplasma gondii. Parasitic cure rates, as judged by failure of brain tissue from surviving mice to produce infection when inoculated into clean mice, were as follows: pyrimethamine + sulfamethoxypyridazine, 92%; clindamycin + sulfamethoxypyridazine, 75%; spiramycin + sulfamethoxypyridazine, 16.7%; trimethoprim + sulfamethoxazole, 16.7%; sulfamethoxypyridazine alone, 0%. Pyrimethamine + sulfamethoxypyridazine was the most effective combination against acute toxoplasmosis in mice.